General Information of Synthetic Binding Protein (SBP) (ID: SBP001765)
SBP Name
scFv anti-HBV PreS1/TACE A9
Synonyms
scFv PreS1/TACE A9
Molecular Weight 30 kDa
Design Method Traditional methods (Site-directed mutagenesis and/or Directed evolution)
Expression System Escherichia coli BL21 (DE3)
Selection Method Phage display
Highest Status Research
Protein Scaffold Information of This SBP
Scaffold ID PS057
Scaffold Info
[1] , [2]
Scaffold Name scFv
Scaffold Class Antibody fragment
Fold Type Beta-Sheets + Loops
Binding Target(s) of This SBP (BTS)
BTS Name Details Mechanism Application Affinity Research Organization Ref
Large envelope protein
BTS Info
Binder Hepatitis B virus infection [ICD-11: XN0GA] Kd: 176 nM Inje University; University of Cambridge [1] , [2]
Disintegrin and metalloproteinase domain-containing protein 17
BTS Info
Binder Hepatitis B virus infection [ICD-11: XN0GA] Kd: 90 nM Inje University; University of Cambridge [1] , [2]
References
1 Improvement of neutralizing activity of human scFv antibodies against hepatitis B virus binding using CDR3 V(H) mutant library. Viral Immunol. Spring 2006;19(1):115-23.
2 Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy. Protein Eng Des Sel. 2014 Jun;27(6):179-90.